D. Boral Capital Downgrades FibroBiologics (FBLG) to Hold
D. Boral Capital analyst Jason Kolbert downgraded FibroBiologics (NASDAQ: FBLG) from Buy to Hold.The analyst comments "We are downgrading FibroBiologics ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)